01.12.2008 | Original Article
Home treatment with Elaprase® and Naglazyme® is safe in patients with mucopolysaccharidoses types II and VI, respectively
Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2008
Einloggen, um Zugang zu erhalten